Ashwagandha
Ashwagandha Root Extr.
- Products
- 1
NIH LiverTox — hepatotoxicity
Category B · Highly likely cause
LiverTox Category B. 2019-2024: rising case reports of idiosyncratic hepatitis. Iceland DHPA 2024 advisory; EU scrutiny ongoing. Heightened risk with existing liver disease or concurrent hepatotoxic drugs.
LiverTox record (NIH NCBI Bookshelf) →Products containing Ashwagandha Root Extr.